Review: taking Celexa and Ranitidine together


Summary

Drug interactions are reported among people who take Celexa and Ranitidine together. This review analyzes the effectiveness and drug interactions between Celexa and Ranitidine. It is created by eHealthMe based on reports of 2,817 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Celexa

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. (latest outcomes from Celexa 39,893 users)

Ranitidine

Ranitidine has active ingredients of ranitidine. It is often used in gastrooesophageal reflux disease. (latest outcomes from Ranitidine 40,405 users)

On Sep, 16, 2016

2,817 people who take Celexa, Ranitidine are studied.


Number of reports submitted per year:

Celexa and Ranitidine drug interactions.

Drug effectiveness over time:

Celexa:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 22.0% - (2 of 9 people)
  • 6 - 12 months: 37.0% - (3 of 8 people)
  • 1 - 2 years: 0.0% - (0 of 10 people)
  • 2 - 5 years: 60.0% - (9 of 15 people)
  • 5 - 10 years: 75.0% - (3 of 4 people)
  • 10+ years: 60.0% - (3 of 5 people)
  • not specified: 0.0% - (0 of 0 people)
Ranitidine:
  • < 1 month: 14.0% - (1 of 7 people)
  • 1 - 6 months: 0.0% - (0 of 6 people)
  • 6 - 12 months: 45.0% - (5 of 11 people)
  • 1 - 2 years: 46.0% - (6 of 13 people)
  • 2 - 5 years: 55.0% - (5 of 9 people)
  • 5 - 10 years: 25.0% - (3 of 12 people)
  • 10+ years: 80.0% - (4 of 5 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Celexa:
  • female: 41.0% - (15 of 36 people)
  • male: 27.0% - (5 of 18 people)
Ranitidine:
  • female: 29.0% - (13 of 44 people)
  • male: 55.0% - (11 of 20 people)

Drug effectiveness by age:

Celexa:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 66.0% - (2 of 3 people)
  • 30-39: 27.0% - (5 of 18 people)
  • 40-49: 33.0% - (4 of 12 people)
  • 50-59: 50.0% - (4 of 8 people)
  • 60+: 38.0% - (5 of 13 people)
Ranitidine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 62.0% - (5 of 8 people)
  • 30-39: 35.0% - (7 of 20 people)
  • 40-49: 26.0% - (4 of 15 people)
  • 50-59: 25.0% - (2 of 8 people)
  • 60+: 46.0% - (6 of 13 people)

Most common drug interactions over time *:

< 1 month:
  • dysphonia
  • urosepsis
  • cough
  • nausea
  • anaemia
  • international normalised ratio increased
  • pulmonary alveolar haemorrhage
  • rhinorrhoea
  • sneezing
  • multi-organ failure
1 - 6 months:
  • cough
  • dysphonia
  • respiratory failure
  • disseminated intravascular coagulation
  • asthma
  • diarrhoea
  • diffuse large b-cell lymphoma
  • hypotension
  • pain
  • pneumonitis
6 - 12 months:
  • electrocardiogram qt prolonged
  • weight gain
  • drug exposure during pregnancy
  • pancreatitis acute on chronic
  • anxiety
  • arthritis
  • cardiac arrest
  • fatigue
  • frequent headaches
  • gastrointestinal haemorrhage
1 - 2 years:
  • arthritis
  • depression
  • anaemia
  • cataract
  • osteoporosis
  • vitamin d deficiency
  • bone loss
  • calcium deficiency
  • diabetes mellitus
  • multiple fractures
2 - 5 years:
  • diarrhoea
  • tremor
  • depression
  • abdominal pain
  • impaired healing
  • jaw fracture
  • muscle spasms
  • oral cavity fistula
  • oral disorder
  • oral herpes
5 - 10 years:
  • depression
  • angiopathy
  • carotid artery stenosis
  • circulatory collapse
  • coronary artery disease
  • deafness
  • dyspnoea exertional
  • emotional distress
  • femur fracture
  • gastrointestinal disorder
10+ years:
  • migraine - common
  • platelet count increased
  • vertigo
  • irritable bowel syndrome aggravated
  • atrial fibrillation
  • hair loss
  • memory impairment
  • micturition urgency
  • multiple fractures
  • osteoarthritis
not specified:
  • pain
  • anxiety
  • depression
  • nausea
  • fall
  • fatigue
  • dyspnoea
  • dizziness
  • back pain
  • vomiting

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • dizziness
  • fatigue
  • vomiting
  • fall
  • depression
  • dyspnoea
  • anxiety
  • diarrhoea
male:
  • anxiety
  • pain
  • depression
  • fall
  • dyspnoea
  • back pain
  • fatigue
  • pain in extremity
  • headache
  • gastrooesophageal reflux disease

Most common drug interactions by age *:

0-1:
  • maternal drugs affecting foetus
  • drug withdrawal syndrome neonatal
  • extrapyramidal disorder
  • hypertonia neonatal
  • premature baby
  • tardive dyskinesia
  • drug exposure during pregnancy
  • grunting
  • hypertonia
  • late metabolic acidosis of newborn
2-9:
  • scar
  • back pain
  • dizziness
  • pain
  • acute sinusitis
  • anaemia
  • angiopathy
  • anhedonia
  • anxiety
  • aortic arteriosclerosis
10-19:
  • nausea
  • vomiting
  • arthritis
  • abdominal pain upper
  • cataract
  • cholecystitis acute
  • depression
  • diabetes mellitus
  • headache
  • viral infection
20-29:
  • pain
  • infection
  • headache
  • dyspnoea
  • vomiting
  • weight decreased
  • bronchitis
  • depression
  • injury
  • osteonecrosis of jaw
30-39:
  • pain
  • fatigue
  • anxiety
  • weight increased
  • depression
  • diarrhoea
  • vomiting
  • dyspnoea
  • rash erythematous
  • diabetes mellitus
40-49:
  • vomiting
  • dizziness
  • depression
  • drug ineffective
  • insomnia
  • gastrooesophageal reflux disease
  • fatigue
  • pain
  • chest pain
  • somnolence
50-59:
  • nausea
  • depression
  • pain
  • fall
  • weight decreased
  • back pain
  • headache
  • anaemia
  • anxiety
  • dizziness
60+:
  • fall
  • pain
  • anxiety
  • diarrhoea
  • dyspnoea
  • fatigue
  • back pain
  • dizziness
  • depression
  • anaemia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Celexa and Ranitidine?

Can you answer these questions?

More questions for: Celexa, Ranitidine

You may be interested in these reviews

More reviews for: Celexa, Ranitidine

On eHealthMe, Celexa (citalopram hydrobromide) is often used to treat depression. Ranitidine (ranitidine) is often used to treat gastrooesophageal reflux disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.